Group 1 - The core point of the article is that Yingke Medical's stock price increased by 5.3% to 40.74 CNY per share, with a trading volume of 445 million CNY and a turnover rate of 2.39%, resulting in a total market capitalization of 26.676 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] - The top circulating shareholder of Yingke Medical is Huabao Fund, which reduced its holdings in the Huabao Zhongzheng Medical ETF by 2.2149 million shares, now holding 12.8002 million shares, representing 2.75% of circulating shares [2] Group 2 - The Huabao Zhongzheng Medical ETF, managed by Hu Jie, has a total asset size of 100.204 billion CNY, with a best fund return of 182.37% and a worst return of -98.01% during Hu Jie's tenure [3] - The Huabao Zhongzheng Medical ETF was established on May 20, 2019, with a latest scale of 26.404 billion CNY, achieving a year-to-date return of 10.25% and a one-year loss of 1.07% [2]
英科医疗股价涨5.3%,华宝基金旗下1只基金位居十大流通股东,持有1280.02万股浮盈赚取2624.04万元